{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:00:47Z","timestamp":1792112447275,"version":"4.4.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Psychology Review"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.cpr.2021.102005","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T18:35:52Z","timestamp":1616783752000},"page":"102005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"special_numbering":"C","title":["Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis"],"prefix":"10.1016","volume":"86","author":[{"given":"Cristina","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"van der Gaag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hok Pan","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximus","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Krcmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Paul","family":"Amminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bechdolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"Cuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison R.","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"McGorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpr.2021.102005_bb0005","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1176\/appi.ajp.2011.10081191","article-title":"At clinical high risk for psychosis: Outcome for nonconverters","volume":"168","author":"Addington","year":"2011","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2010.10.015","article-title":"A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis","volume":"125","author":"Addington","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/appi.ajp.2019.18111290","article-title":"Characterizing covariant trajectories of individuals at clinical high risk for psychosis across symptomatic and functional domains","volume":"177","author":"Allswede","year":"2019","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.schres.2018.07.022","article-title":"Enhancing social functioning in young people at ultra high risk (UHR) for psychosis: A pilot study of a novel strengths and mindfulness-based online social therapy","volume":"202","author":"Alvarez-Jimenez","year":"2018","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biopsych.2019.08.030","article-title":"The NEURAPRO biomarker analysis: Long-chain omega-3 fatty acids improve 6-month and 12-month outcomes in youths at ultra-high risk for psychosis","volume":"87","author":"Amminger","year":"2020","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: A randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0035","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1038\/ncomms8934","article-title":"Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study","volume":"6","author":"Amminger","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.cpr.2021.102005_bb0040","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00213-019-05442-6","article-title":"Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis","volume":"237","author":"Appiah-Kusi","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cpr.2021.102005_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: A practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evidence-Based Mental Health"},{"key":"10.1016\/j.cpr.2021.102005_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001454","article-title":"Comparative efficacy of seven psychotherapeutic interventions for patients with depression: A network meta-analysis","volume":"10","author":"Barth","year":"2013","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.cpr.2021.102005_bb0055","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/schbul\/sbr083","article-title":"Rationale and baseline characteristics of PREVENT: A second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis","volume":"37","author":"Bechdolf","year":"2011","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1192\/bjp.bp.109.066357","article-title":"Preventing progression to first-episode psychosis in early initial prodromal states","volume":"200","author":"Bechdolf","year":"2012","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1751-7893.2007.00013.x","article-title":"Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: Effects on social adjustment post treatment","volume":"1","author":"Bechdolf","year":"2007","journal-title":"Early Intervention in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.schres.2018.12.047","article-title":"Clinical and functional long-term outcome of patients at clinical high risk (CHR) for psychosis without transition to psychosis: A systematic review","volume":"210","author":"Beck","year":"2019","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/acps.12847","article-title":"Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: An umbrella review of meta-analyses","volume":"137","author":"Belbasis","year":"2018","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.cpr.2021.102005_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jamapsychiatry.2014.2637","article-title":"Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: A randomized clinical trial","volume":"72","author":"van den Berg","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-235307","article-title":"Treatment of social anxiety disorder and attenuated psychotic symptoms with cannabidiol","volume":"13","author":"Berger","year":"2020","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.cpr.2021.102005_bb0090","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2018.2309","article-title":"Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: A randomized clinical trial","volume":"75","author":"Bhattacharyya","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0095","article-title":"Interventions for prodromal stage of psychosis","volume":"11","author":"Bosnjak Kuharic","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.cpr.2021.102005_bb0100","author":"Cadenhead"},{"key":"10.1016\/j.cpr.2021.102005_bb0105","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/schbul\/sbx021.042","article-title":"Omega-3 fatty acid versus placebo in a clinical high-risk sample from the North American Prodrome Longitudinal Studies (NAPLS) consortium","volume":"43","author":"Cadenhead","year":"2017","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0110","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamapsychiatry.2013.1909","article-title":"Prediction of functional outcome in individuals at clinical high risk for psychosis","volume":"70","author":"Carri\u00f3n","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1037\/prj0000217","article-title":"Pupillometer-based neurofeedback cognitive training to improve processing speed and social functioning in individuals at clinical high risk for psychosis","volume":"40","author":"Choi","year":"2017","journal-title":"Psychiatric Rehabilitation Journal"},{"key":"10.1016\/j.cpr.2021.102005_bb0120","series-title":"Statin use for the prevention of cardiovascular disease in adults: A systematic review for the U.S. Preventive Services Task Force","author":"Chou","year":"2016"},{"key":"10.1016\/j.cpr.2021.102005_bb0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/schbul\/sbx093","article-title":"N-acetylcysteine in a double-blind randomized placebo-controlled trial: Toward biomarker-guided treatment in early psychosis","volume":"44","author":"Conus","year":"2018","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0130","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/schbul\/sbr136","article-title":"Risk factors for psychosis: Impaired social and role functioning","volume":"38","author":"Cornblatt","year":"2012","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0135","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.schres.2015.05.014","article-title":"Baseline grey matter volume of non-transitioned \u201cultra high risk\u201d for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up","volume":"173","author":"Cropley","year":"2016","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/wps.20526","article-title":"Lack of evidence to favor specific preventive interventions in psychosis: A network meta-analysis","volume":"17","author":"Davies","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fpsyt.2018.00187","article-title":"Efficacy and acceptability of interventions for attenuated positive psychotic symptoms in individuals at clinical high risk of psychosis: A network meta-analysis","volume":"9","author":"Davies","year":"2018","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0150","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0140-6736(19)32127-0","article-title":"Changing the landscape for type 1 diabetes: The first step to prevention","volume":"394","author":"Dayan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cpr.2021.102005_bb0155","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.4088\/JCP.16m11365","article-title":"A supervised exercise intervention for youth at risk for psychosis: An open-label pilot study","volume":"78","author":"Dean","year":"2017","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: An update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.cpr.2021.102005_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1016\/j.cpr.2021.102005_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/eip.12677","article-title":"Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta-analysis","volume":"13","author":"Devoe","year":"2019","journal-title":"Early Intervention in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/eip.12689","article-title":"Interventions and social functioning in youth at risk of psychosis: A systematic review and meta-analysis","volume":"13","author":"Devoe","year":"2019","journal-title":"Early Intervention in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0180","article-title":"Interventions and transition in youth at risk of psychosis: A systematic review and meta-analyses","volume":"81","author":"Devoe","year":"2020","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0185","article-title":"Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study","author":"Devoe","year":"2020","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0190","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/schbul\/sbx139","article-title":"Negative symptom interventions in youth at risk of psychosis: A systematic review and network meta-analysis","volume":"44","author":"Devoe","year":"2018","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0195","series-title":"Australian clinical guidelines for early psychosis, 2nd edition update, 2016","author":"Early Psychosis Guidelines Writing Group and EPPIC National Support Program","year":"2016"},{"key":"10.1016\/j.cpr.2021.102005_bb0200","article-title":"Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts?","author":"Formica","year":"2020","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S2215-0366(15)00039-5","article-title":"Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): A parallel, single-blind, randomised controlled trial with a mediation analysis","volume":"2","author":"Freeman","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.schres.2019.07.016","article-title":"Treatable clinical intervention targets for patients with schizophrenia","volume":"211","author":"Freeman","year":"2019","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0215","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S2215-0366(15)00314-4","article-title":"Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): A prospective, assessor-blind, randomised controlled pilot trial","volume":"2","author":"Freeman","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0220","article-title":"Neurocognitive and social cognitive training for youth at clinical high risk (CHR) for psychosis: A randomized controlled feasibility trial","author":"Friedman-Yakoobian","year":"2020","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0225","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2020.31","article-title":"The interplay between childhood trauma, cognitive biases, and cannabis use on the risk of psychosis in nonclinical young adults in Poland","volume":"63","author":"Frydecka","year":"2020","journal-title":"European Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0230","doi-asserted-by":"crossref","unstructured":"Fusar-Poli, P. (2017). Negative psychosis prevention trials. JAMA Psychiatry, 74, 6511. doi:https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.0185.","DOI":"10.1001\/jamapsychiatry.2017.0185"},{"key":"10.1016\/j.cpr.2021.102005_bb0235","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fpsyt.2019.00764","article-title":"Preventive treatments for psychosis: Umbrella review (just the evidence)","volume":"10","author":"Fusar-Poli","year":"2019","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0240","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fpsyt.2020.00394","article-title":"Methodological biases in CBT trial-commentary: Modular cognitive-behavioral therapy for affective symptoms in young individuals at ultra-high risk of first episode of psychosis: Randomized controlled trial","volume":"11","author":"Fusar-Poli","year":"2020","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0245","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1192\/bjp.bp.114.157115","article-title":"Disorder, not just state of risk: Meta-analysis of functioning and quality of life in people at high risk of psychosis","volume":"207","author":"Fusar-Poli","year":"2015","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0250","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamapsychiatry.2019.4779","article-title":"Prevention of psychosis: Advances in detection, prognosis, and intervention","volume":"77","author":"Fusar-Poli","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0255","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/schbul\/sbs105","article-title":"Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: A randomized controlled clinical trial","volume":"38","author":"van der Gaag","year":"2012","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0260","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2013.07.004","article-title":"Preventing a first episode of psychosis: Meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups","volume":"149","author":"van der Gaag","year":"2013","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0265","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2017.08.018","article-title":"CBT in the prevention of psychosis and other severe mental disorders in patients with an at risk mental state: A review and proposed next steps","volume":"203","author":"van der Gaag","year":"2019","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0270","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2020.08.016","article-title":"Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial","volume":"224","author":"Glenth\u00f8j","year":"2021","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cpr.2021.102005_bb0275","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/eip.12483","article-title":"Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk","volume":"13","author":"Hartmann","year":"2019","journal-title":"Early Intervention in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0280","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.schres.2015.11.026","article-title":"Declining transition rates to psychotic disorder in \u201cultra-high risk\u201d clients: Investigation of a dilution effect","volume":"170","author":"Hartmann","year":"2016","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0285","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.schres.2019.10.016","article-title":"The prognostic significance of attenuated psychotic symptoms in help-seeking youth","volume":"215","author":"Hazan","year":"2020","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0290","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1037\/0033-2909.92.2.490","article-title":"Estimation of effect size from a series of independent experiments","volume":"92","author":"Hedges","year":"1982","journal-title":"Psychological Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/cp.12132","article-title":"Application of a mindfulness and compassion-based approach to the at-risk mental state","volume":"21","author":"Hickey","year":"2017","journal-title":"Clinical Psychologist"},{"key":"10.1016\/j.cpr.2021.102005_bb0300","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.cpr.2021.102005_bb0305","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cpr.2021.102005_bb0310","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1352465813000313","article-title":"A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis","volume":"42","author":"Holzer","year":"2014","journal-title":"Behavioural and Cognitive Psychotherapy"},{"key":"10.1016\/j.cpr.2021.102005_bb0315","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0033291713000354","article-title":"Cognitive behavioural therapy for psychosis prevention: A systematic review and meta-analysis","volume":"44","author":"Hutton","year":"2014","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.cpr.2021.102005_bb0320","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"Ioannidis","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.cpr.2021.102005_bb0325","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/schbul\/sbw018","article-title":"Four-year follow-up of cognitive behavioral therapy in persons at ultra-high risk for developing psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial","volume":"42","author":"Ising","year":"2016","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0330","first-page":"365","article-title":"Four-year cost-effectiveness of cognitive behavior therapy for preventing first-episode psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) trial","volume":"43","author":"Ising","year":"2017","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0335","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1017\/S0033291714002530","article-title":"Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: Multi-Centre randomized controlled trial","volume":"45","author":"Ising","year":"2015","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.cpr.2021.102005_bb0340","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2019.11.016","article-title":"Acceptance- and mindfulness-based interventions for persons with psychosis: A systematic review and meta-analysis","volume":"215","author":"Jansen","year":"2020","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0345","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5888","article-title":"Evaluation of the cost-effectiveness of services for schizophrenia in the UK across the entire care pathway in a single whole-disease model","volume":"3","author":"Jin","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.cpr.2021.102005_bb0350","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S2215-0366(15)00098-X","article-title":"D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: A pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial","volume":"2","author":"Kantrowitz","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0355","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1192\/bjp.2018.191","article-title":"Individual placement and support for vocational recovery in first-episode psychosis: Randomised controlled trial","volume":"214","author":"Killackey","year":"2019","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0360","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.schres.2017.05.032","article-title":"Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort","volume":"192","author":"Kline","year":"2018","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166139","article-title":"Explaining the decline in coronary heart disease mortality in the Netherlands between 1997 and 2007","volume":"11","author":"Koopman","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cpr.2021.102005_bb0370","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/eip.12871","article-title":"Stepping up early treatment for help-seeking youth with at-risk mental states: Feasibility and acceptability of a real-world exercise program","volume":"14","author":"Lederman","year":"2020","journal-title":"Early Intervention in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0375","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0380","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1176\/appi.ajp.2014.13030418","article-title":"Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis","volume":"172","author":"Lin","year":"2015","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0385","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/schbul\/sbw009","article-title":"Intensive auditory cognitive training improves verbal memory in adolescents and young adults at clinical high risk for psychosis","volume":"42","author":"Loewy","year":"2016","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0390","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/eb-2015-102088","article-title":"A primer on network meta-analysis with emphasis on mental health","volume":"18","author":"Mavridis","year":"2015","journal-title":"Evidence-Based Mental Health"},{"key":"10.1016\/j.cpr.2021.102005_bb0395","author":"McFarlane"},{"key":"10.1016\/j.cpr.2021.102005_bb0400","first-page":"314","article-title":"A randomized clinical trial of family-aided assertive community treatment for young persons at high risk for onset of an initial psychosis","volume":"37","author":"McFarlane","year":"2011","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0405","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1176\/ajp.2006.163.5.790","article-title":"Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis","volume":"163","author":"McGlashan","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0410","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0920-9964(02)00439-5","article-title":"The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. Study rationale and design","volume":"61","author":"McGlashan","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0415","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/wps.20514","article-title":"Beyond the \u201cat risk mental state\u201d concept: Transitioning to transdiagnostic psychiatry","volume":"17","author":"McGorry","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0420","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.schres.2020.12.026","article-title":"Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis","volume":"228","author":"McGorry","year":"2021","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cpr.2021.102005_bb0425","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jamapsychiatry.2019.4635","article-title":"Clinical high risk for psychosis\u2014Not seeing the trees for the wood","volume":"77","author":"McGorry","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamapsychiatry.2016.2902","article-title":"Effect of \u03c9-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: The NEURAPRO randomized clinical trial","volume":"74","author":"McGorry","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0435","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4088\/JCP.12m07785","article-title":"Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: Twelve-month outcome","volume":"74","author":"McGorry","year":"2013","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0440","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00127-020-01913-w","article-title":"Transcending false dichotomies and diagnostic silos to reduce disease burden in mental disorders","volume":"55","author":"McGorry","year":"2020","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1016\/j.cpr.2021.102005_bb0445","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","article-title":"Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms","volume":"59","author":"McGorry","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0450","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2017","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0455","first-page":"848","article-title":"Family-focused treatment for adolescents and young adults at high risk for psychosis: Results of a randomized trial","volume":"53","author":"Miklowitz","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.cpr.2021.102005_bb0465","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/schbul\/sbl042","article-title":"Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk","volume":"33","author":"Morrison","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0470","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2233","article-title":"Early detection and intervention evaluation for people at risk of psychosis: Multisite randomised controlled trial","volume":"344","author":"Morrison","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.cpr.2021.102005_bb0475","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1192\/bjp.185.4.291","article-title":"Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial","volume":"185","author":"Morrison","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0480","series-title":"NICE clinical guideline 178","article-title":"Psychosis and schizophrenia in adults: Prevention and management","author":"National Institute for Health and Care Excellence (NICE)","year":"2014"},{"key":"10.1016\/j.cpr.2021.102005_bb0485","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S2215-0366(19)30513-9","article-title":"Evidence for preventive treatments in young patients at clinical high risk of psychosis: The need for context","volume":"7","author":"Nelson","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0490","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fpsyt.2018.00502","article-title":"Recent meta-analyses in the clinical high risk for psychosis population: Clinical interpretation of findings and suggestions for future research","volume":"9","author":"Nelson","year":"2018","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0495","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fpsyt.2020.00488","article-title":"Commentary: Preventive treatments for psychosis: Umbrella review (just the evidence)","volume":"11","author":"Nelson","year":"2020","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41537-018-0052-x","article-title":"NEURAPRO: A multi-Centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders\u2014Medium-term follow-up and clinical course","volume":"4","author":"Nelson","year":"2018","journal-title":"NPJ Schizophrenia"},{"key":"10.1016\/j.cpr.2021.102005_bb0505","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/eip.12459","article-title":"Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients","volume":"12","author":"Nelson","year":"2018","journal-title":"Early Intervention in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0510","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2016.04.040","article-title":"Further examination of the reducing transition rate in ultra high risk for psychosis samples: The possible role of earlier intervention","volume":"174","author":"Nelson","year":"2016","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0515","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2007.05.018","article-title":"Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis","volume":"96","author":"Phillips","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0520","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/00048670903107625","article-title":"Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: Study design and baseline characteristics","volume":"43","author":"Phillips","year":"2009","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0525","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.psychres.2014.10.021","article-title":"Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis","volume":"225","author":"Piskulic","year":"2015","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0530","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.schres.2018.01.022","article-title":"Clinical trajectories in the ultra-high risk for psychosis population","volume":"197","author":"Polari","year":"2018","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0535","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jclp.22901","article-title":"Modular cognitive-behavioral therapy for affective symptoms in young individuals at ultra-high risk of first episode of psychosis: Randomized controlled trial","volume":"76","author":"Pozza","year":"2020","journal-title":"Journal of Clinical Psychology"},{"key":"10.1016\/j.cpr.2021.102005_bb0540","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.schres.2010.07.026","article-title":"Randomized-controlled trials in people at ultra high risk of psychosis: A review of treatment effectiveness","volume":"123","author":"Preti","year":"2010","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0545","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2020"},{"key":"10.1016\/j.cpr.2021.102005_bb0550","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6215-11-30","article-title":"A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: The Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial","volume":"11","author":"Rietdijk","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.cpr.2021.102005_bb0555","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/jce.14429","article-title":"Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: A meta-analysis","volume":"31","author":"Saglietto","year":"2020","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.cpr.2021.102005_bb0560","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fpsyt.2017.00211","article-title":"Systemic therapy for youth at clinical high risk for psychosis: A pilot study","volume":"8","author":"Shi","year":"2017","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0565","doi-asserted-by":"crossref","first-page":"f185","DOI":"10.1136\/bmj.f185","article-title":"Early interventions to prevent psychosis: Systematic review and meta-analysis","volume":"346","author":"Stafford","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.cpr.2021.102005_bb0570","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.schres.2016.08.008","article-title":"A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial","volume":"176","author":"Stain","year":"2016","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0575","series-title":"STATA statistical software (release 16 ed.)","author":"StataCorp","year":"2019"},{"key":"10.1016\/j.cpr.2021.102005_bb0580","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.brat.2004.06.020","article-title":"Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?","volume":"42","author":"Tarrier","year":"2004","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.cpr.2021.102005_bb0585","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1601-5215.2012.00651.x","article-title":"Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: A 6-month follow-up","volume":"24","author":"Urben","year":"2012","journal-title":"Acta Neuropsychiatrica"},{"key":"10.1016\/j.cpr.2021.102005_bb0590","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.euroneuro.2014.02.008","article-title":"Adolescents at ultra-high risk for psychosis: Long-term outcome of individuals who recover from their at-risk state","volume":"24","author":"de Wit","year":"2014","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.cpr.2021.102005_bb0595","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1093\/schbul\/sbx021.150","article-title":"Effects of ziprasidone versus placebo in patients at clinical high risk for psychosis","volume":"43","author":"Woods","year":"2017","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0600","author":"Woods"},{"key":"10.1016\/j.cpr.2021.102005_bb0605","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2020.05.008","article-title":"Commentary. Toward a core outcomes assessment set for clinical high risk","volume":"227","author":"Woods","year":"2021","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cpr.2021.102005_bb0610","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.euroneuro.2012.09.008","article-title":"Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies","volume":"23","author":"Woods","year":"2013","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.cpr.2021.102005_bb0615","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/schbul\/sbm114","article-title":"Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor","volume":"34","author":"Wykes","year":"2008","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0620","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/wps.20424","article-title":"Treatment of people at ultra-high risk for psychosis","volume":"16","author":"Yung","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0625","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/schbul\/22.2.283","article-title":"Monitoring and care of young people at incipient risk of psychosis","volume":"22","author":"Yung","year":"1996","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2021.102005_bb0630","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.schres.2018.10.019","article-title":"Persistent negative symptoms in individuals at ultra high risk for psychosis","volume":"206","author":"Yung","year":"2019","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0635","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2008.07.012","article-title":"Validation of \u201cprodromal\u201d criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up","volume":"105","author":"Yung","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.03.014","article-title":"The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid?","volume":"120","author":"Yung","year":"2010","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0645","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4088\/JCP.08m04979ora","article-title":"Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis","volume":"72","author":"Yung","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.cpr.2021.102005_bb0650","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(02)00167-6","article-title":"Psychosis prediction: 12-month follow up of a high-risk (\u201cprodromal\u201d) group","volume":"60","author":"Yung","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2021.102005_bb0655","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/schbul\/sbm015","article-title":"Declining transition rate in ultra high risk (prodromal) services: Dilution or reduction of risk?","volume":"33","author":"Yung","year":"2007","journal-title":"Schizophrenia Bulletin"}],"container-title":["Clinical Psychology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735821000489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735821000489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:35:18Z","timestamp":1759466118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272735821000489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":131,"alternative-id":["S0272735821000489"],"URL":"https:\/\/doi.org\/10.1016\/j.cpr.2021.102005","relation":{},"ISSN":["0272-7358"],"issn-type":[{"value":"0272-7358","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Psychology Review","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpr.2021.102005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102005"}}